G 1 Therapeutics Inc (GTHX)

Finanzdaten der G 1 Therapeutics Inc-Aktie (GTHX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	2.67% 14.48	14.87	12.30	42.39	12.95
Operating Expenses	1.17% 23.52	23.80	28.67	30.88	38.69
Benefits Costs and Expenses	0.62% 24.70	24.85	29.60	32.37	40.54
Costs And Expenses	0.62% 24.70	24.85	29.60	32.37	40.54
Operating Income/Loss	1.33% -9.048	-8.929	-16.37	11.52	-25.75
Income/Loss From Continuing Operations Before Tax	2.44% -10.22	-9.976	-17.30	10.02	-27.59
Income Tax Expense/Benefit	100.00% -	0.902	0.905	1.308	-
Income/Loss From Continuing Operations After Tax	6.06% -10.22	-10.88	-18.20	8.71	-27.59
Net Income/Loss	6.06% -10.22	-10.88	-18.20	8.71	-27.59
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	146.87K% 52.17	0.0355	51.78	51.67	51.65
Diluted Average Shares	146.87K% 52.17	0.0355	51.78	61.04	51.65
Basic Earnings Per Share	4.76% -0.20	-0.21	-0.35	0.17	-0.53
Diluted Earnings Per Share	4.76% -0.20	-0.21	-0.35	0.14	-0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-